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Background: Although in the past decade occidental countries have increasingly recognized the personal and
societal burden of migraine, it remains poorly understood in Africa. No study has evaluated the impact of sleep
disturbances and the quality of life (QOL) in sub-Saharan Africans with migraine.
Methods: This was a cross-sectional study evaluating adults, ≥ 18 years of age, attending outpatient clinics in Ethiopia.
Standardized questionnaires were utilized to collect demographic, headache, sleep, lifestyle, and QOL characteristics in all
participants. Migraine classification was based on International Classification of Headache Disorders (ICHD)-II criteria. The
Pittsburgh Sleep Quality Index (PSQI) and the World Health Organization Quality of Life (WHOQOL-BREF) questionnaires
were utilized to assess sleep quality and QOL characteristics, respectively. Multivariable logistic regression models were fit
to estimate adjusted odds ratio (OR) and 95% confidence intervals (95% CI).
Results: Of 1,060 participants, 145 (14%) met ICHD-II criteria for migraine. Approximately three-fifth of the study
participants (60.5%) were found to have poor sleep quality. After adjustments, migraineurs had over a two-fold
increased odds (OR = 2.24, 95% CI 1.49-3.38) of overall poor sleep quality (PSQI global score >5) as compared with
non-migraineurs. Compared with non-migraineurs, migraineurs were also more likely to experience short sleep
duration (≤7 hours) (OR = 2.07, 95% CI 1.43-3.00), long sleep latency (≥30 min) (OR = 1.97, 95% CI 1.36-2.85), daytime
dysfunction due to sleepiness (OR = 1.51, 95% CI 1.12-2.02), and poor sleep efficiency (<85%) (OR = 1.93, 95% CI 1.31-2.88).
Similar to occidental countries, Ethiopian migraineurs reported a reduced QOL as compared to non-migraineurs.
Specifically Ethiopian migraineurs were more likely to experience poor physical (OR = 1.56, 95% CI 1.08-2.25) and
psychological health (OR = 1.75, 95% CI 1.20-2.56), as well as poor social relationships (OR = 1.56, 95% CI 1.08-2.25),
and living environments (OR = 1.41, 95% CI 0.97-2.05) as compared to those without migraine.
Conclusion: Similar to occidental countries, migraine is highly prevalent among Ethiopians and is associated with poor
sleep quality and a lower QOL. These findings support the need for physicians and policy makers to take action to
improve the quality of headache care and access to treatment in Ethiopia.
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Migraine is a common neurological disorder characterized
by localized, intense, throbbing or pulsing sensations in the
head, which is often accompanied by nausea, vomiting,
photophobia and phonophobia [1]. Globally migraine is
responsible for roughly 3% of disability making it the 8th
most burdensome disease [2]. Research on migraine and* Correspondence: bgelaye@hsph.harvard.edu
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reproduction in any medium, provided the origprimary headache disorders is relatively expansive in
volume, but not in geographical scope, with the majority
of research coming from higher income countries, and
disproportionately less knowledge coming from lower
income countries. In sub-Saharan Africa, where only five
countries have contributed to primary headache disorder
research, nine articles have been published in the span of
almost ten years (1997–2006) [3]. In the past five years,
there have been few studies investigating the burden of
migraine [4-12] in accordance with International Classifi-
cation of Headache Disorder (ICHD) criteria. A recentThis is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
inal work is properly credited.
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prevalence of 9.8% comparable to what is reported in
occidental countries (10-15%) [5].
Sleep disorders, affecting more than 45% of the world’s
population, have emerged as important global public health
problems [13,14]. An emerging body of epidemiologic evi-
dence supports that sleep disorders are highly prevalent
among sub-Saharan Africans [15,16]; and are important risk
factors for headache attacks [17,18] as well as other adverse
health outcomes [19-24]. Specifically, studies have shown
that sleep disorders are associated with daytime sleepiness
(assessed by direct observation and/or based on self-report),
and reduced perception of overall quality of life (QOL) [25].
However the health consequences of sleep disorders have
not been thoroughly evaluated among sub-Saharan Africans.
Additionally, disrupted sleep-wake patterns have been shown
to predispose individuals to headache attacks and increase
the risk of chronification [17,18,26]. Further, improvement in
sleep quality has long been described as beneficial for migrai-
neurs [27].
Studies have also shown that migraineurs are more
likely to have a lower QOL as compared with non-
migraineurs [28,29]. Measures of QOL provide a quanti-
tative assessment of an individual’s social relationships,
living environment, physical and psychological health
status [30]. QOL measures also provide the aggregate
burden imposed by specific health conditions such as
migraine headache and sleep disturbances [31]. To the
best of our knowledge, no study has comprehensively
evaluated the burden of sleep disturbances and QOL
among sub-Saharan African migraineurs. Given the in-
creased understanding of migraine prevalence among
sub-Saharan Africans, it is crucial to gain a better under-
standing of migraine and its relationship with sleep
disturbances and QOL in this population. Information
from this and similar studies may provide the evidence
needed for developing preventive and therapeutic strat-
egies designed to mitigate the burden of both conditions
in these and other understudied populations.
Methods
Design and participants
This study consisted of 1,060 participants who attended
the Saint Paul General Hospital outpatient facility (M/F:
423/637; mean age 35.7 ± 12.1 years) in Addis Ababa,
Ethiopia. The hospital provides all basic services across
various medical departments including: pediatrics, internal
medicine, gynecology, neurology, general surgery, psych-
iatry, ophthalmology, and emergency medicine. For this
study only patients evaluated in the internal medicine,
general surgery and gynecological outpatient departments
were eligible for inclusion. Data collection was conducted
between July and December, 2011. Study personnel in-
cluded research nurses with public health training. Priorto the start of the study, research nurses participated in a
four- day training session that included training modules
on the contents of the questionnaire, ethical conduct of
human subjects research, and appropriate data collection
techniques. Structured in-person interviews were used to
collect information regarding demographics, headache
characteristics, sleep disturbances, QOL, and behavioral
and lifestyle characteristics. The interview included a
structured migraine assessment questionnaire (adapted
from previously validated structured interviews although
not specifically validated in our study population) [32,33].
The questionnaire was first written in English and then
translated by linguistic experts into Amharic and was
translated back into English. Using a recruitment script,
research nurses approached patients and invited them for
participation. Approximately 85% of individuals who were
invited to participate in the study elected to do so. All
study participants provided informed consent and all
research protocols were approved by the Institutional
Review Boards of Addis Continental Institute of Public
Health, Addis Ababa, Ethiopia and the Human Subjects
Division at the University of Washington, Seattle, USA.
Variable specification
Migraine was classified based on the ICHD-II criteria [34].
Migraine (ICHD-II category 1.1 or 1.2) was defined by at
least five lifetime headache attacks (criterion A) lasting
4–72 hours (criterion B), with at least two of the qualifying
pain characteristics [unilateral location (criterion C1),
pulsating quality (criterion C2), moderate or severe pain
intensity (criterion C3), aggravation by routine physical
exertion (criterion C4)]; at least one of the associated
symptoms [nausea and/or vomiting (criterion D1), photo/
phonophobia (criterion D2)]; and not attributable to
another central nervous system disorder or head trauma
(according to subject self-report) (criterion E).
Pittsburgh Sleep Quality Index (PSQI)
Sleep quality was assessed using the Pittsburgh Sleep
Quality Index (PSQI) [35]. The PSQI is a 19-item self-
reported, validated questionnaire that evaluates sleep
quality within the past month. The PSQI consists of
seven sleep components related to sleep habits including
duration of sleep, sleep disturbance, sleep latency, habitual
sleep efficiency, use of sleep medicine, daytime dysfunc-
tion and overall sleep quality. The sleep components yield
a score ranging from 0 to 3, with three indicating the
greatest dysfunction [35]. The sleep component scores are
summed to yield a total score ranging from 0 to 21, with
higher total or global scores indicating poor sleep quality.
Based on prior literature [35], participants with a global
score greater than 5 were classified as poor sleepers.
Those with a score of 5 or less were classified as good
sleepers.
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variable of optimal and suboptimal sleep quality was
utilized. Specific categories included long sleep latency
(≥30 minutes vs. < 30 minutes); poor sleep efficiency
(<85% vs. ≥85%); days dysfunction due to sleep (< once a
week vs. ≥ once per week); and sleep medication use
during the past month (< once per week vs. ≥ once per
week). Sleep duration was assessed using the PSQI ques-
tionnaire that queried participants how many hours of
actual sleep the participants got at night during the
previous month. In accordance with the original scale,
the following groupings were used to define sleep
duration: <5 hours, 5.1-5.9 hours, 6–6.9 hours, and ≥
7 hours. Those in the lowest three groups of sleep dur-
ation (<7 hours) were classified as short duration sleepers.
World Health Organization quality of life questionnaire
The WHO QOL questionnaire (WHO-QOL) [36] is a
cross-cultural assessment tool that captures an individual’s
perception of their position in life in the context of culture
and the value systems in which they live and in relation to
their goals, expectations, standards and concerns [36]. In
the current study the abbreviated version of WHO-QOL,
the WHOQOL-BREF, was utilized and includes 26 items
across four domains. The physical domain consists of
questions about daily activities, dependence on medication
and treatment, energy and exhaustion, mobility, pain
and discomfort, sleep and rest, and capacity to work.
The psychological domain consists of questions about
positive and negative feelings, self-esteem, body image
and external image, personal beliefs, and attention. The
social relationships domain consists of questions about
relationships with others, social support, and sex life. The
environmental domain of the scale consists of questions
about the home environment, physical security and safety,
financial resources, availability of health services, leisure
activities, physical environment, and transportation. The
overall percentile score for each domain ranges from 0%
(very poor) to 100% (very good).
Covariates
Questions were also included regarding behavioral risk
factors such as tobacco, alcohol, and khat consumption.
Khat is an evergreen plant with amphetamine-like effects
commonly used as a mild stimulant for social recreation
and to improve work performance in Ethiopia [37,38].
Participants were classified according to their alcohol
consumption habits: nondrinker (<1 alcoholic beverage a
week), moderate (1–21 alcoholic beverages a week), and
high to excessive consumption (>21 alcoholic beverages
a week) according to the WHO classification [39]. Other
variables were categorized as follows: age (years), sex
(male, female), education (≤ high school, technical
school, ≥ bachelor’s degree), smoking history (never,former, current), and current Khat consumption (yes,
no). Participants were also asked the following question
about their self-reported health status derived from the
WHO questionnaire [40]: “Would you say your health in
general is excellent, very good, good, fair, or poor?” and
were classified into those who reported fair or poor
health and those who reported excellent, very good, or
good health. Self-reported health status is an important
construct that provides vital information about how one
perceives and report’s one’s own well-being [41].
Statistical analysis
All analyses were performed using SPSS Version 22.0,
(IBM SPSS Version 22, Chicago, IL,). Demographic and
lifestyle characteristics of study participants were assessed
using means (± standard deviation) for continuous vari-
ables and counts and percentages for categorical variables.
For skewed variables median [interquartile range] were
provided. Differences in categorical variables were evalu-
ated using Chi-square test or Fisher’s exact test as appro-
priate. For continuous variables with normal distributions,
Student’s t-tests were used to evaluate differences in mean
values by migraine status. Unadjusted, age and sex-
adjusted, and multivariable models, were fit to estimate
odds ratios (ORs) and 95% confidence intervals (CI) for
the associations of migraine and sleep quality parameters
(i.e., sleep duration, latency, efficiency and overall sleep
quality, daytime dysfunction and sleep medicine use in the
past month). Multivariable-adjusted logistic regression
models controlled for age, sex, body mass index, alcohol
consumption, and smoking status. Confounding variables
were considered a priori for documented associations of
migraine [42] with sleep disorders and QOL. Independent
sample t-tests were used to compare differences in mean
values for QOL scores. To determine statistically signifi-
cant correlates of migraine among the QOL domains, we
performed similar unadjusted and multivariate-adjusted
logistic regression models as described above. Given
the lack of standard cut-offs for the domains in the
WHOQOL-BREF, we used quartiles to define the groups
and used the lowest quartile as the reference group in the
analyses. All reported p-values are two-sided and defined
as significant at the 5% level.
Results
Migraine prevalence
Table 1 reports the demographic characteristics of the
sample. Of 1,060 participants, 145 (14%) met ICHD-II
criteria for migraine. A majority of the sample were
women (60.1%), married (51.3%), and with less than a
12th grade education (78.4%). Approximately 4% reported
current smoking status, while 56.7% reported no alcohol
consumption in the past year. Current khat consumption
was reported by 20.6% of participants. Poor physical
Table 1 Characteristics of the study population (N = 1,060)
N = 1,060
Characteristic n %






Never married 335 31.7
Other 180 17.0
Education (years)
≤ Primary (1–6) 474 44.7
Secondary (7–12) 357 33.7





Alcohol consumption past year
Non-drinker 601 56.7
< once a month 357 33.7











Excellent/very good/good 596 56.2
Poor/fair 464 43.8
Self-reported mental health
Excellent/very good/good 699 65.9
Poor/fair 361 34.1
*Mean ± standard deviation (SD).









Characteristic n (%) n (%) n (%) P-value*
Sleep duration (hours)
<5 106 (10.0) 17 (11.7) 89 (9.7) 0.002
5-5.9 126 (11.9) 27 (18.6) 99 (10.8)
6-6.9 227 (21.4) 39 (26.9) 188 (20.6)
≥7 601 (56.7) 62 (42.8) 539 (58.9)
Sleep latency (minutes)
≤15 293 (27.6) 32 (22.1) 261 (28.5) <0.001
16-30 259 (24.4) 23 (15.9) 236 (25.8)
31-60 277 (26.1) 41 (28.3) 236 (25.8)
>60 231 (21.8) 49 (33.8) 182 (19.9)
Day dysfunction
due to sleep
Never 443 (41.8) 44 (30.3) 399 (43.6) 0.001
< once a week 383 (36.1) 57 (39.3) 326 (35.6)
1-2 times per week 189 (17.8) 31 (21.4) 158 (17.3)
≥3 times per week 45 (4.2) 13 (8.9) 32 (3.5)
Sleep efficiency (%)
≥85 461 (43.5) 45 (31.0) 416 (45.5) 0.012
75-84 140 (13.2) 23 (15.9) 117 (12.8)
65-74 81 (7.6) 15 (10.3) 66 (7.2)
<65 378 (35.7) 62 (42.8) 316 (34.5)
Sleep medicine
during past month
Never 1,024 (96.6) 136 (93.8) 888 (97.0) 0.039
< once a week 7 (0.7) 2 (1.4) 5 (0.6)
1-2 times per week 13 (1.2) 5 (3.4) 8 (0.9)
≥3 times per week 16 (1.5) 2 (1.4) 14 (1.5)
Overall sleep quality
Good 419 (39.8) 35 (24.1) 384 (42.0) <0.001
Poor 641 (60.2) 110 (75.9) 531 (58.0)
*Chi-square test or Fisher’s test (when the sample size in a cell < 5).
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34.1% of the sample, respectively. Overall, migraine preva-
lence was greater among women (16.8%) than men (8.9%),
p < 0.001.
Sleep habits/patterns and migraine
Table 2 summarizes sleep quality parameters (PSQI sleep
component scales). 43.3% of subjects reported short sleepduration <7 hours, while 47.9% of subjects reported long
sleep latency (>30 minutes). Overall, 599 (56.5%) and 234
(22%) subjects reported poor sleep efficiency (<85%) and
daytime dysfunction more than once a week, respectively.
Some 60.2% of participants were classified as having sub-
optimal/poor overall sleep quality. Overall, there was no
statistically significant difference between men and women
with regards to sleep duration, sleep latency, daytime dys-
function, sleep efficiency, sleep medicine use or overall
sleep quality (data not shown). Participants’ characteristics,
according to migraine status, are summarized in Table 2.
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ation, long sleep latency, daytime dysfunction due to
sleepiness, poor sleep efficiency, and sleep medication use
during the past month as compared with non-migraineurs.
Overall, poor sleep quality (PSQI global score > 5) was
more common among migraineurs as compared with
non-migraineurs (75.9% vs. 58.0%).
The odds ratios (OR) for migraine across the PSQI
sleep quality parameters are shown in Table 3. In the
multivariable-adjusted model, migraineurs were more likely
than non-migraineurs to report short sleep duration
(<7 hours) (OR = 2.05, 95% CI 1.42-2.97), long sleep latency
(>30 min) (OR = 1.97, 95% CI 1.36-2.85), daytime dysfunc-
tion due to sleepiness (OR = 1.50, 95% CI 1.00-2.25), and
poor sleep efficiency (<85%) (OR = 1.94, 95% CI 1.32-2.85).
Migraineurs also had a 1.73-fold increased odds of taking
sleep medications (95% CI 0.68-4.39) than non-migraineurs
although statistical significance was not achieved. Finally,
migraineurs had a 2.26-fold increased odds (OR = 2.26,
95% CI 1.50-3.39) of overall poor sleep quality (PSQI global
score >5) as compared with non-migraineurs.
Quality of life and migraine
As shown in Table 4, when compared with non-
migraineurs, migraineurs scored significantly lower in all
four WHO-QOL domains measured. In the physical
domain, mean scores for migraineurs were significantly
lower (−3.7 points; p value = 0.003) than non-migraineurs.
In the psychological domain, migraineurs had a mean scoreTable 3 Odds Ratios (OR) and 95% Confidence Intervals (CI) o
Sleep quality parameters Unadjusted Age and se
Poor sleep quality
No 1.00 (Reference) 1.00 (Refere
Yes 2.27 (1.52-3.39) 2.31 (1.59-3
Short sleep duration (<7 hours)
No 1.00 (Reference) 1.00 (Refere
Yes 1.91 (1.34-2.73) 2.01 (1.40-2
Long sleep latency (>30 min)
No 1.00 (Reference) 1.00 (Refere
Yes 1.94 (1.36-2.79) 1.90 (1.32-2
Day dysfunction due to sleep
No 1.00 (Reference) 1.00 (Refere
Yes 1.66 (1.12-2.45) 1.60 (1.08-2
Poor sleep efficiency (<85%)
No 1.00 (Reference) 1.00 (Refere
Yes 1.85 (1.27-2.69) 1.92 (1.31-2
Sleep medicine use
No 1.00 (Reference) 1.00 (Refere
Yes 2.06 (0.86-4.91) 1.68 (0.66-4
*Adjusted for age, sex, body mass index, alcohol consumption, smoking status.of 56.2 as compared with 49.0 among non-migraineurs
(p < 0.001). The mean score differential between migrai-
neurs and non-migraineurs were 6.0 (p = 0.004) and 4.0
(p = 0.005) in the social and environmental domains,
respectively.
Table 5 shows the association between migraine and
the WHO-QOL domains. In the multivariable-adjusted
model, compared with non-migraineurs, migraineurs were
more likely to experience poor physical health (OR = 1.56,
95% CI 1.08-2.25), psychological health (OR = 1.75,
95% CI 1.20-2.56), social relationships (OR = 1.56, 95% CI
1.08-2.25), and living environment (OR = 1.41, 95% CI
0.97-2.05).
Discussion
In this study of sub-Saharan Africans approximately
14% of the study sample was found to have migraine
while more than 60% of participants were classified as
having poor sleep quality. Migraineurs, as compared with
non-migraineurs, were more likely to report experiences
of short sleep duration, long sleep latency, daytime
dysfunction due to sleepiness, poor sleep efficiency and
overall poor sleep quality, independent of age, sex,
BMI, alcohol consumption and smoking status. Fur-
thermore, migraineurs were more likely to report
having significantly impaired QOL as compared with
non-migraineurs.
A majority of study participants (60.5%) were classified
as having poor sleep quality. This finding is consistentf sleep quality in relation migraine status



















No (N = 915) Yes (N = 145)
Mean score SD Mean score SD
Physical 51.6 13.7 47.9 12.2 0.003
Psychological 56.2 18.0 49.0 18.3 <0.001
Social relationships 63.8 22.9 57.8 24.3 0.004
Environmental 42.3 16.0 38.3 14.4 0.005
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epidemiologic studies. Nuhu et al. [43], in their study of
primary care patients attending an outpatient clinic in
Nigeria, reported that 68.7% of participants had poor
sleep quality [43]. Similarly Zhu et al. [44], in a study of
Chinese migraineurs recruited from a tertiary hospital
headache clinic, reported poor sleep quality among 61.6%
of participants. Investigations of sleep quality in other
populations, however, have reported lower prevalence
rates. For instance Minowa et al. [46], using the PSQI, re-
ported that 30-45% of 4,868 Japanese white-collar workers
suffered from poor sleep quality, while Hoefelmann et al.
[45] reported that 21% of 47,304 Brazilian industrial
workers had poor sleep quality. At least in part, these dif-
ferences across studies may be attributable to differences
in geographic locations, operational definitions of sleep
quality and characteristics of the study populations.
Over the past three decades, the importance of proper,
sustained sleep has garnered increasing interest within
the public health community [47]. Both migraine and
sleep disturbances overlap in symptom profiles with
other chronic disorders. Poor sleep quality and habits
have been linked to loss of work productivity [46,48],
impaired QOL [49,50], increased risk for cardiovascularTable 5 Odds Ratios (OR) and 95% Confidence Intervals (CI) o
WHOQOL-BREF Unadjusted Age and sex
Poor physical health
No 1.00 (Reference) 1.00 (Referen
Yes 1.55 (1.08-2.22) 1.56 (1.09-2.2
Poor psychological health
No 1.00 (Reference) 1.00 (Referen
Yes 1.80 (1.24-2.59) 1.76 (1.21-2.5
Poor social relationships
No 1.00 (Reference) 1.00 (Referen
Yes 1.49 (1.04-2.13) 1.57 (1.09-2.2
Poor living environment
No 1.00 (Reference) 1.00 (Referen
Yes 1.42 (0.98-2.04) 1.38 (0.95-2.0
*Adjusted for age, sex, body mass index, alcohol consumption, smoking status; WH
version of.diseases [49], and psychiatric morbidities [18,51-54]. The
co-morbidities with poor sleep quality and other sleep
disturbances are well documented, primarily in high-
income countries [54-56]. Our study expands the litera-
ture by providing evidence that these associations with
poor sleep and reduced quality of sleep in migraineurs
extends to lower income countries.. Given the under-
recognition and under-treatment of migraine and sleep
disorders in sub-Saharan Africa and other low and mid-
dle income regions of the world, these findings will have
important clinical and global public health implications.
Understanding their comorbidity may provide opportun-
ities to enhance the diagnoses and treatment of these
prevalent disorders.
We found migraineurs had increased odds of experien-
cing poor QOL in all domains compared with non-
migraineurs. This finding is in agreement with prior lit-
erature. For instance, in their population-based study of
Russian adults, Ayzenberg et al. [28] found that migrai-
neurs were more likely to have poor WHOQOL scores
compared with non-migraineurs (27.1 ± 4.9 vs. 30.5 ±
4.5; p < 0.05). Similarly Arslantas et al. [57] in Turkey re-
ported that migraineurs had significantly impaired health
related QOL across all domains of the 36-item short-
form (SF-36) except for the general health perception, so-
cial functioning, and role-emotional domains. In sub-
Saharan Africa where migraine diagnosis and treatment
remain very low, the impairments in QOL might cause
distress and frustration for the migraineurs and their fam-
ilies. The results of the present study and those of others
[28] further support the importance of early identification
and that proper treatment of migraine can significantly
improve QOL.
Migraine episodes are largely commonplace with regular
onset patterns –either at night or in the early morningf quality of life in relation to migraine









OQOL-BREF: World Health Organization quality of life questionnaire abbreviated
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patterns may influence or exacerbate migraine symptoms
[18,58]. Several plausible and compelling biological mech-
anisms have been proposed underlying the observed
migraine–sleep disorder association. Some investigators
suspect an underlying connection is controlled by the
hypothalamus-pituitary- adrenal axis (HPA), in which the
hypothalamus may not respond efficiently to physiological
triggers instigated by sleep disturbances [18,58]. Migrai-
neurs with aura often report several common premonitory
symptoms including yawning and daytime sleepiness,
which are hypothesized to be mediated by dopamine and
influenced by the HPA axis. Conversely, Engstrom et al.
[59] hypothesize that arousability is mediated by the auto-
nomic nervous system and possibly alters pain thresholds
among migraineurs. Further, given that migraine is pri-
marily understood as a neurovascular condition, hypoth-
eses related to increased sensitivity to vasodilation may
explain the link between migraine and sleep disturbances
[60,61].
Several limitations of this work must be taken into con-
sideration. First, we used a cross-sectional study design,
which restricts the assertion of temporality between
migraine, sleep disorders and QOL. Future prospective
studies in which sleep quality habits and QOL are
recorded in migraineurs and non-migraineurs would
allow for better understanding of the directionality of
reported association. Second, our study population con-
sists of patients who attended the Saint Paul General
Hospital outpatient facility, thereby limiting the gen-
eralizability of our study findings to a broader general
population. Third, migraine diagnosis was made based
upon information collected using a well-established struc-
tured questionnaire [32,33]. Use of structured interviews
remains the most feasible method of data collection for
large scale epidemiologic studies. Further, the potential of
recall bias must be considered as participants were asked
to report sleep habits over the past month to address
PSQI questions. Lastly, subjective sleep quality and habits
were measured using the self-administered PSQI assess-
ment tool. While the PSQI assess subjective sleep quality, it
is a leading assessment tool, tested for internal consistency
[35] and used to ascertain sleep quality parameters in
diverse global populations [62,63].
Results from our study indicate that similar to occiden-
tal countries, migraine is highly prevalent in Ethiopia; and
that those with migraine have increased odds of experien-
cing poor sleep quality and lower QOL. Migraine is a
disabling neurological disorder with substantial impact
on personal health, work productivity, QOL and co-
morbidity with other chronic diseases [2]. The findings
of our study and those of others from sub-Saharan Af-
rica re-iterate that migraine is not a mere inconvenience
as it is often portrayed [4-12] and support the need forphysicians and policy makers to take action to improve
the quality of headache care and access to treatment in
sub-Saharan Africa.
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